Advertisement
Advertisement
U.S. Markets open in 3 hrs 2 mins
Advertisement
Advertisement
Advertisement
Advertisement

Reviva Pharmaceuticals Holdings, Inc. (RVPH)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
3.5100-0.1200 (-3.31%)
At close: 04:00PM EST
3.5000 -0.01 (-0.28%)
After hours: 04:41PM EST
Advertisement

Reviva Pharmaceuticals Holdings, Inc.

19925 Stevens Creek Boulevard
Suite 100
Cupertino, CA 95014
United States
408 501 8881
http://www.revivapharma.com

Sector(s)Healthcare
IndustryBiotechnology
Full Time Employees5

Key Executives

NameTitlePayExercisedYear Born
Dr. Laxminarayan BhatFounder, CEO, Pres & Director247.95kN/A1965
Mr. Narayan PrabhuChief Financial OfficerN/AN/A1972
Dr. Marc CantillonChief Medical OfficerN/AN/A1959
Amounts are as of December 31, 2020 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Reviva Pharmaceuticals Holdings, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and seeks to commercialize next-generation therapeutics for diseases representing unmet medical needs in the areas of central nervous system, respiratory, cardiovascular, metabolic, and inflammatory diseases. Its lead product candidate is RP5063 that has completed Phase II clinical trials for the treatment of schizophrenia, as well as completed Phase I clinical trials for treating bipolar disorder, major depressive disorder, behavioral and psychotic symptoms, dementia or Alzheimer's disease, parkinson's disease psychosis, attention deficit hyperactivity disorder, pulmonary arterial hypertension, and idiopathic pulmonary fibrosis; and RP1208 that has completed pre-clinical development studies for the treatment of depression and obesity. The company is based in Cupertino, California.

Corporate Governance

Reviva Pharmaceuticals Holdings, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Advertisement
Advertisement